EDITAS MEDICINE INC.

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

12 Aug 2024 09:46:03 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

09 Aug 2024 10:12:14 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

07 Aug 2024 11:59:49 By NetDania Notify

Editas Medicine Announces Second Quarter 2024 Results and Business Updates

07 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

05 Aug 2024 09:45:15 By NetDania Notify

Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update

31 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

02 Jul 2024 09:45:34 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

01 Jul 2024 14:01:29 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

28 Jun 2024 09:47:12 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

27 Jun 2024 09:45:34 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

26 Jun 2024 10:52:15 By NetDania Notify

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

17 Jun 2024 10:19:53 By NetDania Notify

Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress

14 Jun 2024 03:01:00 By Nasdaq GlobeNewswire

Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual Congress

14 Jun 2024 03:00:00 By Nasdaq GlobeNewswire

Editas Medicine to Present Clinical Data from the RUBY and EdiTHAL Trials of Reni-cel at the European Hematology Association 2024 Congress in June

14 May 2024 10:00:00 By Nasdaq GlobeNewswire

Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting

10 May 2024 06:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: EDITAS MEDICINE INC. - COMMON STOCK

08 May 2024 09:49:21 By NetDania Notify

Editas Medicine Announces First Quarter 2024 Results and Business Updates

08 May 2024 07:00:01 By Nasdaq GlobeNewswire

Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events

02 May 2024 07:00:00 By Nasdaq GlobeNewswire

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

01 May 2024 08:00:01 By Nasdaq GlobeNewswire